XML 118 R126.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Assets - Financial investments in quoted shares, current derivatives and Non-current loans to EEAA (Details)
€ in Thousands, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2018
USD ($)
Jun. 30, 2018
EUR (€)
Oct. 02, 2017
USD ($)
Oct. 02, 2017
EUR (€)
Feb. 08, 2017
USD ($)
Feb. 08, 2017
EUR (€)
Apr. 30, 2019
Jun. 30, 2018
Dec. 31, 2019
EUR (€)
Dec. 31, 2018
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2020
EUR (€)
Singulex, Inc.                        
Financial Assets                        
Impairment loss recognized in statement of profit and loss | €                 € 35,565      
Indirect ownership interest (as a percent)               19.33%        
Alkahest, Inc.                        
Financial Assets                        
Loans to associates | $                   $ 100,000    
Interest rate on non-current loans (as a percent)                   5.00%    
Amount used by the associate                     $ 20,000 € 18,342
Grifols Diagnostics Solutions, Inc. | Singulex, Inc.                        
Financial Assets                        
Loans to associates $ 12,339 € 11,063 $ 20,000 € 16,676                
Interest rate on non-current loans (as a percent)     5.00% 5.00%                
Grifols Worldwide Operations Limited | Interstate Blood Bank, Inc. (USA)                        
Financial Assets                        
Loans to associates         $ 11,000 € 10,809            
Interest rate on non-current loans (as a percent)         4.00% 4.00%            
Interstate Blood Bank, Inc. (USA)                        
Financial Assets                        
Ownership interest in subsidiary (as a percent)             100.00%